Brain atrophy plagues more than just people with neurodegenerative disorders...
An ultra-high-resolution 3D map of the human brain promises to help scientists studying neuroanatomy, neurosurgery, neurodegenerative disease, and more.
Similar to Alzheimer's disease, PD dementia begins with subtle deficits in cognition that progress to symptoms recognizable as mild cognitive impairment.
Epilepsy’s ties with Alzheimer’s disease occur earlier than previously thought.
G8 leaders set 2025 as their goal to find better treatment for Alzheimer's and vowed to coordinate research and care strategies.
The April issue of Health Affairs is dedicated to Alzheimer’s. Authors gathered in Washington, D.C., to articulate how world policy could take shape.
Exome sequencing identifies a new Alzheimer’s risk gene—phospholipase D3.
Researchers at BACE meeting explore how trafficking and degradation of the protease relate to amyloid pathology in AD.
Are New Cognitive Tests Ready For Preclinical Trials? Do Tau Tracers Track Cognitive Decline in Disease? Growth Factor Therapy: Safe in Phase 1, Awaiting Efficacy Data Clinical Trials on Alzheimer’s Disease 2013 ...
Older people improved memory and attention after playing a challenging video game, supporting the idea that multitasking could have benefits for cognition.
Leaders protest recent decision to deny Medicare beneficiaries coverage of amyloid scans.
Update on compounds in Phase 2 and 3 trials from the Alzheimer's Association International Conference
Studies reported at AAIC demonstrate that biomarkers help predict who will develop cognitive impairment and dementia.
A close-up of the protein mayhem within the synaptic bouton offers scientists an unprecedented glimpse of the activity inside.
Researchers are increasingly branching out from their old focus on Aβ and tau to understand how these proteins intersect with physiological processes and new genetic regulatory mechanisms in the aging brain.